Making The Leap From EU MDD To MDR Clinical Evidence (Part 2): Differences In Expectations
Executive Summary
Maetrics’ Amie Smirthwaite explains the fundamental differences in clinical evidence expectations under the MDR compared with the MDD in part two of a three-part interview.
You may also be interested in...
Making The Leap From EU MDD To MDR Clinical Evidence (Part 1): Practical Advice
Clinical evidence requirements are among the biggest challenges for manufacturers meeting the requirements of the EU’s new Medical Device Regulation. Maetrics’ Amie Smirthwaite explains how manufacturers should transition from the one to the other in part one of a three-part interview series with Medtech Insight.
EU Regulatory Roundup, March 2024: Busy Agenda In Broad Range Of Key Areas
March was an important month for EU medtech regulation with an interesting spread of news relating to the Medical Device and IVD Regulations, the Batteries Regulation, the Artificial Intelligence Act and more.
EU’s Revised Phthalates Guideline Features New Annexes Focused On Alternatives
The effects of phthalates, plasticizers used in many medical devices, on the human endocrine system, have long been debated. But how safe are the alternatives? Updated guidelines give more insight.